Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash Flows from Operating Activities:
Net income (loss)	$ 17,215	$ 50,367
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation expense, intangible asset and other amortization	21,557	19,810
Stock-based compensation	10,113	11,384
Amortization of deferred commissions	1,038	1,805
Payments of deferred commissions	(974)	(973)
Equity in earnings of equity method investments	93	(1,209)
(Gain) loss on extinguishment of debt	(705)	0
Distributions from equity method investments	726	675
Sales (purchases) of investments, net	4,703	13,767
Deferred taxes, net	5,014	252
Changes in operating assets and liabilities:
Accounts receivable, net and other assets	(2,032)	(2,394)
Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities	(52,788)	(44,325)
Operating activities of consolidated investment products (CIP):
Net cash provided by (used in) operating activities	(449,712)	(143,668)
Cash Flows from Investing Activities:
Capital expenditures and other asset purchases	(475)	(6,111)
Sale of available-for-sale securities	0	2,044
Net cash provided by (used in) investing activities	9,249	(5,638)
Cash Flows from Financing Activities:
Payment of long term debt	(44,059)	(24,825)
Common stock dividends paid	(11,320)	(8,392)
Preferred stock dividends paid	(2,084)	(4,168)
Repurchases of common shares	(17,500)	(22,499)
Proceeds from exercise of stock options	114	643
Taxes paid related to net share settlement of restricted stock units	(5,569)	(6,509)
Net subscriptions received from (redemptions/distributions paid to) noncontrolling interests	(3,951)	6,599
Net cash provided by (used in) financing activities	370,577	145,934
Net increase (decrease) in cash, cash equivalents and restricted cash	(69,886)	(3,372)
Cash, cash equivalents and restricted cash, beginning of period	321,939	254,656
Cash, cash equivalents and restricted cash, end of period	252,053	251,284
Non-Cash Investing Activities:
Change in accrual for capital expenditures	(21)	(1,813)
Non-Cash Financing Activities:
Increase (decrease) to noncontrolling interests due to consolidation (deconsolidation) of CIP, net	17,137	(6,423)
Common stock dividends payable	5,169	3,849
Preferred stock dividends payable	0	2,084
Conversion of preferred stock to common stock	115,000	0
Reconciliation of cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at end of period	252,053	251,284
Consolidated entity excluding consolidated investment products
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Realized and unrealized (gains) losses on investments, net	431	(4,634)
Consolidated Investment Products
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Realized and unrealized (gains) losses on investments, net	11,603	(13,222)
Operating activities of consolidated investment products (CIP):
Purchases of investments by CIP	(920,392)	(532,342)
Sales of investments by CIP	442,859	348,771
Net proceeds (purchases) of short term investments by CIP	68	(309)
(Purchases) sales of securities sold short by CIP, net	250	1,193
Change in other assets of CIP	(1,790)	71
Change in liabilities of CIP	2,130	3,140
Amortization of discount on notes payable of CIP	11,169	4,505
Cash Flows from Investing Activities:
Change in cash and cash equivalents of CIP due to consolidation (deconsolidation), net	9,724	(1,571)
Cash Flows from Financing Activities:
Payments on borrowings by CIP	(326,201)	(195,697)
Borrowings by CIP	$ 781,147	$ 400,782